---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
 |
 Pharmacist e-Link CE Spotlight |
 |
 |
The Safety of COX-2 Pharmacotherapy for Patients in Pain
There are anecdotal reports about the COX-2 inhibitors of improved efficacy over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc. |
 |
The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P. |
|
 |
Self-Care Management for the Diabetic Patient: Focus on Skin & Nutrition
Pharmacists can contribute to enhanced understanding of self-care for patients with diabetes by evaluating the patient's capacity for self-care, identifying areas for improved knowledge of diabetes, educating patients in appropriate self-care strategies, and training patients to monitor self-care measures. This program focuses on two aspects of diabetes self-care education that the community pharmacist can substantially impact – skin care and nutrition.
This program is supported by an educational grant from Health Care Products. |
 |
COPD in the Long-Term Care Setting (Enduring)
The goal of this program is to inform healthcare professionals on the prevalence, diagnosis, risk factors and management of COPD in the long term care setting. The quality of life issues, activities of daily living and the prognosis of this progressive disease will be addressed.
This educational program is sponsored by The GMR Group-Health Insights and supported by Boehringer Ingelheim. |
 |
Quality Improvement Opportunities in Managing Depression Measuring Performance Through Benchmarking
This activity will discuss the effect of depression on both patients and employers, and review the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) diagnostic criteria and American Psychiatric Association Practice Guidelines. Also, the 2006 HEDIS® (Health Plan Employer Data and Information Set) antidepressant medication management measures will be discussed, with a focus on strategies for optimizing the management of patients with depression.
This activity is supported by an educational grant from Wyeth Pharmaceuticals. |
 |
Common Misconceptions with Bioequivalence and Interchangeability
This CE program examines the bioequivalence and interchangeability of drugs. Since several factors can influence the bioavailability of drugs, this activity highlights instances where sub-therapeutic responses, alterations in outcomes, or adverse events can be consequences of pharmacokinetic interactions.
This program is co-sponsored by ArcMesa Educators and Scinexa, LLC. |
 |
Pharmacy Customer Satisfaction: A Key to Business Success
This program will present results from the 2004 Boehringer Ingleheim Pharmacy Satisfaction Digest derived from the WilsonRx™ Pharmacy Survey, which surveyed over 26,000 households and identified the retail customer's perception of their pharmacy. It also measured the level of satisfaction with their store on more than 40 pharmacy related issues as well as importance ratings and satisfaction with health insurance and PBM related issues, and includes treatment satisfaction for up to 40 conditions.
This program is supported by an educational grant from Boehringer Ingelheim. |
 |
Strategies in the Prevention of Cardiovascular Events and Mortality in the High-Risk Older Population
Cardiovascular disease (CVD) is a substantial US healthcare burden, with about 40% of all US deaths annually as a result of cardiovascular events. Hypertension alone is the most common risk factor for CVD and the most frequent medical condition prompting visits to primary healthcare providers. Current initiatives examine not only pharmacologic treatment, but also lifestyle changes that are focused on the prevention of CVD in the elderly. It is to the advantage of managed care to understand potential treatment options proposed by these studies for reducing the CVD burden.
Supported through an educational grant from Wyeth and King Pharmaceuticals. |
|
|
